Loading…

4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies

Background Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors...

Full description

Saved in:
Bibliographic Details
Published in:BMC chemistry 2016-08, Vol.10 (1), p.53-53, Article 53
Main Authors: Ikome, Hermia N., Ntie-Kang, Fidele, Ngemenya, Moses N., Tu, Zhude, Mach, Robert H., Efange, Simon M. N.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93
cites cdi_FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93
container_end_page 53
container_issue 1
container_start_page 53
container_title BMC chemistry
container_volume 10
creator Ikome, Hermia N.
Ntie-Kang, Fidele
Ngemenya, Moses N.
Tu, Zhude
Mach, Robert H.
Efange, Simon M. N.
description Background Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane ( 1 ) analogues as functional ligands (agonists) for σ receptors by chemical modification. Results Chemical modification of the core structure of the lead compound, ( 1 ), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands 7a–f , 8a–f and 9d–e . The sigma-1 receptor affinities of 7e , 8a and 8f were slightly lower than that of 1 and their selectivities for this receptor two to threefold greater than that of 1 . Conclusions It was found that these compounds have higher selectivities for sigma-1 receptors compared to 1 . Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions. Graphical abstract Identified pharmacophore features for sigma binding.
doi_str_mv 10.1186/s13065-016-0200-1
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4994268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4204294661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93</originalsourceid><addsrcrecordid>eNqNks2K1TAYhosozjh6AW6k4GYEo0nz17oQZJhRYcCNgruQJl_bDGlTk_ZgL8mlN-I12c4ZhzOC4CoJ75P3--HNsqcEvyKkFK8ToVhwhIlAuMAYkXvZMZG8QITTr_cP7kfZo5SuMOYlEfJhdlRIznkpq-PsB0M6hsWPboTorBsg5XqwOUOnv36ibrExfF_GDobFv7jDpDyBBzO5HeTJtb1GJI9gYJxCzL1rV5P0Jk_LMHWQXHqZjxG8692g45KPnY69NsGH1hntc9hpP-vJheG6uAn9OE_X71VM02wdpMfZg0b7BE9uzpPsy8X557MP6PLT-49n7y6REZhNiPJ1J8xSUxpL64I1RDIGpqkLIwtrq4I2tpaUCVLVpiGClqIRgmvTVFZaU9GT7O3ed5zrHqyBYYraqzG6fm1dBe3UXWVwnWrDTrGqYoUoV4PTG4MYvs2QJtW7ZMB7PUCYkyIl47KSlLL_QAkjVDJOVvT5X-hVmOO6n40qeFWKkm3Nkz1lYkgpQnPbN8Fqy4zaZ0atmVFbZtTm_Oxw4Nsff0KyAsUeSKs0tBAPSv_T9TdP5tLi</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1825986849</pqid></control><display><type>article</type><title>4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies</title><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Ikome, Hermia N. ; Ntie-Kang, Fidele ; Ngemenya, Moses N. ; Tu, Zhude ; Mach, Robert H. ; Efange, Simon M. N.</creator><creatorcontrib>Ikome, Hermia N. ; Ntie-Kang, Fidele ; Ngemenya, Moses N. ; Tu, Zhude ; Mach, Robert H. ; Efange, Simon M. N.</creatorcontrib><description>Background Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane ( 1 ) analogues as functional ligands (agonists) for σ receptors by chemical modification. Results Chemical modification of the core structure of the lead compound, ( 1 ), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands 7a–f , 8a–f and 9d–e . The sigma-1 receptor affinities of 7e , 8a and 8f were slightly lower than that of 1 and their selectivities for this receptor two to threefold greater than that of 1 . Conclusions It was found that these compounds have higher selectivities for sigma-1 receptors compared to 1 . Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions. Graphical abstract Identified pharmacophore features for sigma binding.</description><identifier>ISSN: 1752-153X</identifier><identifier>EISSN: 1752-153X</identifier><identifier>EISSN: 2661-801X</identifier><identifier>DOI: 10.1186/s13065-016-0200-1</identifier><identifier>PMID: 27555879</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Affinity ; Chemical compounds ; Chemistry ; Chemistry and Materials Science ; Chemistry/Food Science ; Diseases ; Drugs ; Hydroxyl groups ; Ligands ; Organic and Medicinal Chemistry ; Pharmaceutical sciences ; Proteins ; Receptors ; Research Article ; Selectivity ; Sulfur</subject><ispartof>BMC chemistry, 2016-08, Vol.10 (1), p.53-53, Article 53</ispartof><rights>The Author(s) 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93</citedby><cites>FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93</cites><orcidid>0000-0003-0795-394X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1825986849/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1825986849?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27555879$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ikome, Hermia N.</creatorcontrib><creatorcontrib>Ntie-Kang, Fidele</creatorcontrib><creatorcontrib>Ngemenya, Moses N.</creatorcontrib><creatorcontrib>Tu, Zhude</creatorcontrib><creatorcontrib>Mach, Robert H.</creatorcontrib><creatorcontrib>Efange, Simon M. N.</creatorcontrib><title>4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies</title><title>BMC chemistry</title><addtitle>Chemistry Central Journal</addtitle><addtitle>Chem Cent J</addtitle><description>Background Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane ( 1 ) analogues as functional ligands (agonists) for σ receptors by chemical modification. Results Chemical modification of the core structure of the lead compound, ( 1 ), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands 7a–f , 8a–f and 9d–e . The sigma-1 receptor affinities of 7e , 8a and 8f were slightly lower than that of 1 and their selectivities for this receptor two to threefold greater than that of 1 . Conclusions It was found that these compounds have higher selectivities for sigma-1 receptors compared to 1 . Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions. Graphical abstract Identified pharmacophore features for sigma binding.</description><subject>Affinity</subject><subject>Chemical compounds</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Chemistry/Food Science</subject><subject>Diseases</subject><subject>Drugs</subject><subject>Hydroxyl groups</subject><subject>Ligands</subject><subject>Organic and Medicinal Chemistry</subject><subject>Pharmaceutical sciences</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Research Article</subject><subject>Selectivity</subject><subject>Sulfur</subject><issn>1752-153X</issn><issn>1752-153X</issn><issn>2661-801X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNks2K1TAYhosozjh6AW6k4GYEo0nz17oQZJhRYcCNgruQJl_bDGlTk_ZgL8mlN-I12c4ZhzOC4CoJ75P3--HNsqcEvyKkFK8ToVhwhIlAuMAYkXvZMZG8QITTr_cP7kfZo5SuMOYlEfJhdlRIznkpq-PsB0M6hsWPboTorBsg5XqwOUOnv36ibrExfF_GDobFv7jDpDyBBzO5HeTJtb1GJI9gYJxCzL1rV5P0Jk_LMHWQXHqZjxG8692g45KPnY69NsGH1hntc9hpP-vJheG6uAn9OE_X71VM02wdpMfZg0b7BE9uzpPsy8X557MP6PLT-49n7y6REZhNiPJ1J8xSUxpL64I1RDIGpqkLIwtrq4I2tpaUCVLVpiGClqIRgmvTVFZaU9GT7O3ed5zrHqyBYYraqzG6fm1dBe3UXWVwnWrDTrGqYoUoV4PTG4MYvs2QJtW7ZMB7PUCYkyIl47KSlLL_QAkjVDJOVvT5X-hVmOO6n40qeFWKkm3Nkz1lYkgpQnPbN8Fqy4zaZ0atmVFbZtTm_Oxw4Nsff0KyAsUeSKs0tBAPSv_T9TdP5tLi</recordid><startdate>20160823</startdate><enddate>20160823</enddate><creator>Ikome, Hermia N.</creator><creator>Ntie-Kang, Fidele</creator><creator>Ngemenya, Moses N.</creator><creator>Tu, Zhude</creator><creator>Mach, Robert H.</creator><creator>Efange, Simon M. N.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7SR</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8BQ</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>JG9</scope><scope>K9.</scope><scope>KB.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0795-394X</orcidid></search><sort><creationdate>20160823</creationdate><title>4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies</title><author>Ikome, Hermia N. ; Ntie-Kang, Fidele ; Ngemenya, Moses N. ; Tu, Zhude ; Mach, Robert H. ; Efange, Simon M. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Affinity</topic><topic>Chemical compounds</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Chemistry/Food Science</topic><topic>Diseases</topic><topic>Drugs</topic><topic>Hydroxyl groups</topic><topic>Ligands</topic><topic>Organic and Medicinal Chemistry</topic><topic>Pharmaceutical sciences</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Research Article</topic><topic>Selectivity</topic><topic>Sulfur</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ikome, Hermia N.</creatorcontrib><creatorcontrib>Ntie-Kang, Fidele</creatorcontrib><creatorcontrib>Ngemenya, Moses N.</creatorcontrib><creatorcontrib>Tu, Zhude</creatorcontrib><creatorcontrib>Mach, Robert H.</creatorcontrib><creatorcontrib>Efange, Simon M. N.</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Engineered Materials Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Materials Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ikome, Hermia N.</au><au>Ntie-Kang, Fidele</au><au>Ngemenya, Moses N.</au><au>Tu, Zhude</au><au>Mach, Robert H.</au><au>Efange, Simon M. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies</atitle><jtitle>BMC chemistry</jtitle><stitle>Chemistry Central Journal</stitle><addtitle>Chem Cent J</addtitle><date>2016-08-23</date><risdate>2016</risdate><volume>10</volume><issue>1</issue><spage>53</spage><epage>53</epage><pages>53-53</pages><artnum>53</artnum><issn>1752-153X</issn><eissn>1752-153X</eissn><eissn>2661-801X</eissn><abstract>Background Sigma (σ) receptors are membrane-bound proteins characterised by an unusual promiscuous ability to bind a wide variety of drugs and their high affinity for typical neuroleptic drugs, such as haloperidol, and their potential as alternative targets for antipsychotic agents. Sigma receptors display diverse biological activities and represent potential fruitful targets for therapeutic development in combating many human diseases. Therefore, they present an interesting avenue for further exploration. It was our goal to evaluate the potential of ring opened spipethiane ( 1 ) analogues as functional ligands (agonists) for σ receptors by chemical modification. Results Chemical modification of the core structure of the lead compound, ( 1 ), by replacement of the sulphur atom with a carbonyl group, hydroxyl group and 3-bromobenzylamine with the simultaneous presence of 4-fluorobenzoyl replacing the spirofusion afforded novel potent sigma-1 receptor ligands 7a–f , 8a–f and 9d–e . The sigma-1 receptor affinities of 7e , 8a and 8f were slightly lower than that of 1 and their selectivities for this receptor two to threefold greater than that of 1 . Conclusions It was found that these compounds have higher selectivities for sigma-1 receptors compared to 1 . Quantitatitive structure–activity relationship studies revealed that sigma-1 binding is driven by hydrophobic interactions. Graphical abstract Identified pharmacophore features for sigma binding.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>27555879</pmid><doi>10.1186/s13065-016-0200-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0795-394X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1752-153X
ispartof BMC chemistry, 2016-08, Vol.10 (1), p.53-53, Article 53
issn 1752-153X
1752-153X
2661-801X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4994268
source Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access ; PubMed Central; Free Full-Text Journals in Chemistry
subjects Affinity
Chemical compounds
Chemistry
Chemistry and Materials Science
Chemistry/Food Science
Diseases
Drugs
Hydroxyl groups
Ligands
Organic and Medicinal Chemistry
Pharmaceutical sciences
Proteins
Receptors
Research Article
Selectivity
Sulfur
title 4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A11%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=4-aroylpiperidines%20and%204-(%CE%B1-hydroxyphenyl)piperidines%20as%20selective%20sigma-1%20receptor%20ligands:%20synthesis,%20preliminary%20pharmacological%20evaluation%20and%20computational%20studies&rft.jtitle=BMC%20chemistry&rft.au=Ikome,%20Hermia%20N.&rft.date=2016-08-23&rft.volume=10&rft.issue=1&rft.spage=53&rft.epage=53&rft.pages=53-53&rft.artnum=53&rft.issn=1752-153X&rft.eissn=1752-153X&rft_id=info:doi/10.1186/s13065-016-0200-1&rft_dat=%3Cproquest_pubme%3E4204294661%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c604t-353064d3c8cd3b24f1744ecfb2c72dd923fdb734619bcf16386f665acf9d7dc93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1825986849&rft_id=info:pmid/27555879&rfr_iscdi=true